Piyush Goyal leads a 60-member delegation to Israel to accelerate India–Israel FTA talks, focusing on trade, defence, agriculture, technology and investment.
Read Full ArticleGranules Life Sciences secures its first U.S. FDA approval for the Hyderabad facility after a successful inspection, marking a major milestone in global expansion.
SC questions if Uniform Code for Pharma Marketing Practices 2024 is truly enforced or just a ‘toothless tiger’, seeks Centre’s response.
The Delhi High Court has ruled in favour of Pharmacyclics LLC and Johnson & Johnson Pvt Ltd (Johnson & Johnson) in a patent infringement suit moved by them for violation of their rights in targeted cancer treatment drug, Ibrutinib, marketed as Imbruvica. Find out all about the case here.
Mumbai ITAT deletes ₹11.59 crore addition under Section 69A, holding broker’s papers and a retracted statement insufficient to prove alleged on-money receipts.
11 March, 2026 04:41 PM
![Pharmacyclics, Johnson & Johnson win patent infringement suit for anti-cancer drug [Read Judgment]](/secure/uploads/2024/01/lj_5765_WhatsApp_Image_2024-01-03_at_5.45.56_PM.jpeg)
